# EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma

> **NCT03772756** · NA · COMPLETED · sponsor: **First People's Hospital of Hangzhou** · enrollment: 38 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma Non-resectable

## Interventions

- **PROCEDURE:** Endoscopic ultrasound guided radiofrequency ablation
- **RADIATION:** chemoradiotherapy

## Key facts

- **NCT ID:** NCT03772756
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2021-08-16
- **Final completion:** 2021-08-16
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03772756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03772756, "EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03772756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*